1. |
Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest, 2009, 135(2): 505-512.
|
2. |
Rubin BK. Physiology of airway mucus clearance. Respir Care, 2002, 47(7): 761-768.
|
3. |
刘峰, 周向东, 余红梅, 等. Elafin对气道上皮细胞黏蛋白5AC的调节作用. 中国呼吸与危重症监护杂志, 2018, 17(3): 296-300.
|
4. |
Chen L, Wang T, Zhang JY, et al. Toll-like receptor 4 relates to lipopolysaccharide-induced mucus hypersecretion in rat airway. Arch Med Res, 2009, 40(1): 10-17.
|
5. |
金生, 张大志, 陈压西, 等. Toll样受体研究进展与临床免疫. 重庆医学, 2004, 33(9): 1423-1426.
|
6. |
Roger T, Froidevaux C, Le Roy D, et al. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci U S A, 2009, 106(7): 2348-2352.
|
7. |
Miyata M, Lee JY, Susuki-Miyata S, et al. Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-MM. Nat Commun, 2015, 6: 6062.
|
8. |
Ringwood L, Li LW. The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation. Cytokine, 2008, 42(1): 1-7.
|
9. |
Heinz LX, Rebsamen M, Rossi DC, et al. The death domain-containing protein Unc5 CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade. Cell Death Differ, 2012, 19(4): 722-731.
|
10. |
Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol, 2003, 3(2): 169-176.
|
11. |
Daigneault J, Klemetsaune L, Wasserman SA. The IRAK homolog pelle is the functional counterpart of IκB kinase in the drosophila toll pathway. PLoS One, 2013, 8(9): e75150.
|
12. |
Potnis PA, Dutta DK, Wood SC. Toll-like receptor 4 signaling pathway mediates proinflammatory immune response to cobalt-alloy particles. Cell Immunol, 2013, 282(1): 53-65.
|